• info@sarvbiolabs.com
  • +91 172 4356615
Sarv Biolabs
Sarv Biolabs
Linkedin Youtube Facebook Instagram File-pdf
Contact us

Oncology APIs & Intermediates

Precision at the Molecular Level - Redefining Oncology Manufacturing

At Sarv Biolabs, drugs are developed at the bench and built from the molecular level up, long before they are administered to the patient. We are an established manufacturer of oncology active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, the foundation upon which cancer treatment throughout the world is built.

Our facility is built on the principles of science, infrastructure, and an unfailing commitment to quality. We collaborate with pharmaceutical companies, formulators, and exporters looking for reliable manufacturing expertise. There is no room for compromise on quality with Sarv Biolabs.

Where Chemistry Meets Cancer Care

Oncology APIs are the key chemical ingredients present in drugs that fight cancer. These are complex molecules that target cancer cells within the body. Pharmaceutical intermediates are chemical compounds synthesized during the production process; they are not the final medicine but are crucial precursors to it.

Together, these two components make up all oncology medications administered to patients. Even the smallest lapse in quality has a direct impact on a patient's cancer treatment.

Sarv Biolabs is a leader in this very area, producing APIs and intermediates that pharma giants trust for their highly sensitive formulations. Only perfection matters here; approximations have no place.

From Molecules to Medicine - Our Product Spectrum

At Sarv Biolabs, we manufacture oncology APIs and pharmaceutical intermediates, including Etoposide and Dasatinib, for pharmaceutical manufacturers worldwide.

Etoposide

Etoposide is a well-known oncology API prescribed for the treatment of multiple cancers, including testicular cancer and lung cancer. This compound inhibits one of the enzymes that cancer cells rely on to reproduce.

Etoposide is commercially synthesized by Sarv Biolabs under pharmaceutical-grade specifications. As a result, formulators and pharmaceutical manufacturers around the world can be confident in the consistency of their products.

Dasatinib

Dasatinib is a precision oncology API used primarily in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. It inhibits two types of proteins that signal cancer cells to proliferate, functioning as an oncology API that suppresses these proteins.

Sarv Biolabs synthesizes and produces this compound under stringent quality processes to meet the needs of pharma companies requiring dependable, pure active ingredients.

As our product list continues to grow, we remain committed to enabling access to affordable and effective cancer treatment worldwide.

A Wide Range of Oncology APIs & Intermediates by Sarv Biolabs

Sarv Biolabs offers a wide spectrum of oncology APIs and intermediates, divided into Finished APIs and Synthesis Intermediates.

Finished APIs

  • Paclitaxel IP/USP/EP
  • Docetaxel Trihydrate IP/USP/EP
  • Docetaxel Anhydrous IP/USP/EP
  • Lenalidomide Base & HCl
  • Etoposide
  • Dasatinib
  • Pomalidomide

Synthesis Intermediates

  • 10-Deacetyl Baccatin III
  • 7-TROC Paclitaxel
  • 7,10-Di-TROC Docetaxel

The Sarv Biolabs Advantage: Precision, Purity, and Partnership

Selecting an oncology manufacturing partner is a decision on which patients’ lives can depend. At Sarv Biolabs, you’ll find a combination of technical skill, a certified facility, and a dedication to quality — a partner, not just a supplier.

We adhere to the pharmaceutical industry’s specific quality requirements and regulations. Our goals extend beyond order fulfillment: building mutually beneficial, long-term relationships.

Choose Sarv Biolabs if your business requires quality, on-time oncology API and intermediate manufacturing. Together, we can build something better.